Literature DB >> 15383602

Absence of procarboxypeptidase R induces complement-mediated lethal inflammation in lipopolysaccharide-primed mice.

Suzuka Asai1, Tomoo Sato, Toyohiro Tada, Tomomi Miyamoto, Noriaki Kimbara, Noboru Motoyama, Hidechika Okada, Noriko Okada.   

Abstract

Carboxypeptidase R (CPR) is a heat-labile enzyme found in serum in addition to stable carboxypeptidase N. CPR cleaves the C-terminal basic amino acids, arginine and lysine, from inflammatory peptides such as complement C3a and C5a, bradykinin, and enkephalin. This enzyme is generated from procarboxypeptidase R (proCPR), also known as thrombin-activatable fibrinolysis inhibitor, following cleavage by proteolytic enzymes such as thrombin, plasmin, and trypsin. We generated proCPR-deficient mice by knocking out exons 4 and 5 of the proCPR gene, which are regarded as essential for CPR function. At LPS challenge, there was virtually no difference in lethality among proCPR(+/+), proCPR(+/-), and proCPR(-/-) mice. However, challenge with cobra venom factor, which can activate and deplete almost all complement in vivo, induced a lethal effect on proCPR(-/-) mice following LPS sensitization which up-regulates C5a receptor expression. In contrast, proCPR(+/+) and proCPR(+/-) mice were able to tolerate the cobra venom factor challenge with the limited dose (30 U). Although carboxypeptidase N plays a role in inactivation of inflammatory peptides in vivo, CPR may also be important in the regulation of hyperinflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383602     DOI: 10.4049/jimmunol.173.7.4669

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.

Authors:  Toshihiko Nishimura; Timothy Myles; Adrian M Piliponsky; Adrian M Piliposky; Peter N Kao; Gerald J Berry; Lawrence L K Leung
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

3.  Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.

Authors:  Mirjam E Meltzer; Carine J M Doggen; Philip G de Groot; Joost C M Meijers; Frits R Rosendaal; Ton Lisman
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

4.  The X-ray structure of carboxypeptidase A inhibited by a thiirane mechanism-based inhibitor.

Authors:  Daniel Fernández; Sebastian Testero; Josep Vendrell; Francesc X Avilés; Shahriar Mobashery
Journal:  Chem Biol Drug Des       Date:  2009-11-04       Impact factor: 2.817

Review 5.  Carboxypeptidases in disease: insights from peptidomic studies.

Authors:  Matthew R Sapio; Lloyd D Fricker
Journal:  Proteomics Clin Appl       Date:  2014-03-24       Impact factor: 3.494

6.  Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.

Authors:  Stacey L Mueller-Ortiz; Dachun Wang; John E Morales; Li Li; Jui-Yoa Chang; Rick A Wetsel
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

Review 7.  Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells.

Authors:  Dmitri Atiakshin; Andrey Kostin; Ivan Trotsenko; Vera Samoilova; Igor Buchwalow; Markus Tiemann
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.